Jobs
View more job listings or post a job
TLL Pharma, High Impact Medicines for All.  Director of Formulation Development
Charles River Labs We are seeking an experienced Scientist I, In Vitro
Charles River Labs We are seeking an experienced Principal Scientist 1, In-Vivo Pharmacokinetics
Charles River Labs We are seeking an experienced Scientist I, Oncology
Charles River Labs We are seeking an experienced Principal Scientist I, In Vitro for our Discovery
Charles River Labs Research Scientist I, In Vivo PK
Charles River Labs We are seeking a highly motivated, experienced Research Scientist 1 - CNS Bioanalytical
Charles River Labs We are seeking a highly motivated, experienced Research Scientist 1 - DMPK Bioanalytical   
Sangamo Therapeutics Nonclinical Project Manager 
Post a job


Position:
Director-DMPK  

Employer:
Aligos Therapeutics

Description:

Aligos Therapeutics, Inc. is a biotechnology company located in South San Francisco, California that is developing novel medicines to treat liver diseases in virology, inflammation/fibrosis and oncology. Aligos is pursuing the development of both oligonucleotide-based and small molecule therapeutics, each addressing major commercial market opportunities.

 

At Aligos, our science is the key to our success, and to improving patients' quality of life. Our pipeline of developing novel compounds and investigative therapies reflects our commitment to bring innovative products to patients with unmet needs in the area of liver diseases. This is an exciting opportunity to become an early employee of a high-energy, Research, and Development company.

 

Position Summary/About the Team:

This position will report to the Head of the Department and be responsible for leading DMPK related scientific strategies within the company. The person will participate in the discovery and development of multi-disciplinary project teams. The position will have high visibility within the company and is expected to contribute directly to the company’s goals and objectives.



Qualifications/Experience:

Essential Functions / Responsibilities:

  • Responsible for strategic and scientific leadership within the department. Will regularly interacts with senior executives of the company to align and execute discovery and development projects.
  • Lead DMPK as a functional representative on discovery and development project teams.
  • Work closely with nonclinical discovery scientists, clinicians, and cross-functional development project team members.
  • Guide discovery project teams for candidate selection, develop and drive  DMPK strategies for lead optimization, and solving ADME-related issues. Design, conduct and interpret in vitro and in vivo DMPK studies. Responsible for determining PK parameters for nonclinical studies using WinNonlin and assist with the application of modeling approaches (in silico, PK, PBPK) to support human pharmacokinetics and dose predictions, quantitative risk assessment of drug-drug interactions.
  • Manage and outsource GLP bioanalysis for nonclinical and clinical studies. Monitor methods development, validation, sample analysis, and review and approve reports.
  • Generate, analyze and present data at internal and external meetings, both orally and as written reports.
  • Author and review various regulatory documents and interact with worldwide regulatory authorities.
  • Manage junior scientists and DMPK budget, decide outsourcing strategies and participate and define future growth strategies for the department.

 

Reasonable accommodations may be made to enable individuals with disabilities to perform these essential functions.

 

Required Education and Experience:

  • Ph.D. or Pharm D. in Pharmacokinetics, Pharmaceutical Sciences, or related field with a specific focus on small molecule pharmacokinetics and metabolism with 12+ years of relevant industry experience.
  • Extensive understanding of DMPK principles. A proven track record of supporting drug discovery and development as a functional representative on multidisciplinary project teams, authoring regulatory documents, supporting worldwide regulatory filings and interactions.
  • Proven skills in pharmacokinetic data analysis using Phoenix WinNonlin.
  • Knowledge of GLP, GCP, drug development, and regulatory guidelines is required.
  • Proven track record for managing budgets and people.

 

Preferred Education and Experience:

 

  • Familiarity with NONMEM, SimCyp, and/or Gastroplus PBPK modeling.
  • Experience in oligonucleotide drug development nice to have. 

 

EEO Statement:

Aligos Therapeutics, Inc. is an Equal Opportunity Employer. We do not discriminate against qualified applicants based upon any protected group status, including but not limited to race, religion, color, creed, sex (including breastfeeding and related conditions), gender identity/gender expression, pregnancy (including childbirth and related conditions), national origin, ancestry, age, marital status, military or veteran status, sexual orientation, genetic information, physical or mental disability or medical condition as defined by applicable equal opportunity laws. Any request for accommodation can be directed to sstakes@aligos.com.

 


Location: South San Francisco

Contact: vgohil@aligos.com

Post Date: 6/25/2021 8:56:25 AM
┬ęPharmaceutical & BioScience Society, International; Last Modified: 8/4/2021; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

Alturas Analytics, Inc. Expert GLP & non-GLP LC-MS/MS, GC-MS/MS bioanalytical & PK/TK analysis services of small & large molecules in any matrix. Discovery through phase IV.
Hypha Discovery Ltd. Synthesis, purification & NMR characterization of drug metabolites at mg-g scale with COAs, including CYP/AOX/FMO metabolites, glucuronides & sulfates
Submit a Text Ad